Modulight

1.14 EUR

+2.25 %

2,817 following
Corporate customer

MODU

First North Finland

Medical Equipment & Services

Health Care

+2.25 %
-1.30 %
-3.98 %
+1.34 %
+5.48 %
-3.98 %
-52.41 %
-
-89.63 %

Modulight operates in the technology industry. The company designs, markets, and produces biomedical laser products used in oncology, genetics, and ophthalmology. The customers primarily consist of hospitals and corporate customers operating in medical technology. In addition to the main business, various value-added services are also offered. Their main market is the US.

Read more
Market cap
48.37M EUR
Turnover
9.6K EUR
P/E (adj.) (26e)
-15.57
EV/EBIT (adj.) (26e)
-11.09
EV/S (26e)
5.42
Dividend yield-% (26e)
-
Coverage
Recommendation
Reduce
Target price
1.20 EUR
Updated
26.04.2026
Disclaimer
Antti Siltanen
Antti Siltanen

Analyst

Latest research

Latest analysis report

Released: 27.04.2026

Latest extensive report

Released: 01.07.2025

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
21.8
2026

Interim report Q2'26

23.10
2026

Interim report Q3'26

Risk
Business risk
Valuation risk
Low
High
ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
CEO Seppo Orsila was interviewed by Antti after Modulight’s Q1 release Inderes Modulight Q1’26: Asiakasaktiviteetti ja yhteistyö lisääntynyt - Inderes Aika: 24.04.2026 klo 14.34 Modulightin kannattavuus parani selkeästi Q1:llä odotusten vastaisesta liikevaihdon laskusta huolimatta...
4/24/2026, 3:04 PM
by Sijoittaja-alokas
7
Could @Antti_Siltanen inquire in the upcoming interview what Modulight’s outlook is regarding the quantum industry and whether Modulight has the capability to manufacture chips that integrate directly into the optical circuits of quantum computers?
4/23/2026, 7:25 AM
by Junnu
7
Cash reserves 9 million. In the last quarter, 0.6 million was burned. Perhaps the cash position will last another couple of years without major investment needs? The quantum side is interesting, in my opinion, as the technology of many leading companies there relies on lasers. Of...
4/25/2026, 7:16 AM
by Junnu
5
I wish Modulight nothing but the best. It’s such a niche field and set of products, especially here in Finland. The performance has just been disappointingly poor, hence the fear that a share issue will be coming at some point. For the sake of the company and the investors, I certainly...
4/25/2026, 12:07 PM
by L Dabio
4
Here is a company report from Siltanen after Modulight’s Q1 results Modulight’s Q1 revenue fell short of the comparison period and our forecast. On the other hand, the result and cash flow were better than our expectations as a result of low costs. The product development pipeline...
4/27/2026, 5:53 AM
by Sijoittaja-alokas
3
I have the same guesses as last time. Modulight sijoituskohteena - #1095 käyttäjältä L_Dabio
4/20/2026, 6:09 AM
by L Dabio
2
The company’s free cash flow was €661,000 in the red. The company has €9 million in cash reserves. The company forecasts revenue and EBIDA growth vs. 2025. Revenue dipped in Q1 vs. Q1/25. Despite this, EBIDA improved significantly. When will the cash run out?
4/25/2026, 7:09 AM
by Jopinaattori
1
Read more on our forum

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.